Pharmaceutical Products for CDER Research Studies - IDIQ
75F40126Q132721 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, with responses due 2026-05-15. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
5/11/2026: Questions and answers: Current or most recent incumbent contractor/vendor name Response: WE Pharma, LLC Previous contract number and/or SAM.gov solicitation number Response: Previous contract number 75F40120D00032 and solicitation number FDASOL1222072. Contract award value or estimated an
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | $17K | 1 | 2026-07-02 |
| COVERMYMEDS PHARMACY LLC | $16K | 1 | 2026-07-02 |
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
| THERACOM, L.L.C. | $38K | 1 | 2026-07-02 |
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
Questions
What is solicitation 75F40126Q132721?
Pharmaceutical Products for CDER Research Studies - IDIQ, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING). Responses are due 2026-05-15.
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.